Health-care companies rose as traders rotated back into sectors that had led during the bull market.

BioVie shares fell despite a positive update on data from a mid-stage trial of an Alzheimer's disease candidate.

Equillium shares slid after the biotech concern agreed to to acquire smaller rival Metacrine.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

09-07-22 1659ET